Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration
International Immunopharmacology · 2024-03 · 130 · 111700
DOI: 10.1016/j.intimp.2024.111700 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-03. Verfasst von Dongxue Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; College of Pharmacy and Research Institute of Pharmac…. Hauptthemen laut MEDLINE: Brain Ischemia, Stroke. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Poststroke inflammation is essential in the mechanism of secondary injury, and it is orchestrated by resident microglia, astrocytes, and circulating immune cells. Edaravone dexborneol (EDB) is a combination of edaravone and borneol that has been identified as a clinical protectant for stroke management. In this study, we verified the anti-inflammatory effect of EDB in the mouse model of ischemia and investigated its modulatory action on inflammation-related cells. C57BL/6 male mice, which had the transient middle cerebral artery occlusion (tMCAO), were treated (i.p.) with EDB (15 mg/kg). EDB administration significantly reduced the brain infarction and improved the sensorimotor function after stroke. And EDB alleviated the neuroinflammation by restraining the polarization of microglia/macrophages and astrocyte toward proinflammatory phenotype and inhibiting the production of proinflammatory cytokines (such as IL-1β, TNF-α, and IL-6) and chemokines (including MCP-1 and CXCL1). Furthermore, EDB ameliorated the MCAO-induced impairment of Blood-brain barrier (BBB) by suppressing the degradation of tight junction protein and attenuated the accumulation of peripheral leukocytes in the ischemic brain. Additionally, systemic EDB administration inhibited the macrophage phenotypic shift toward the M1 phenotype and the macrophage-dependent inflammatory response in the spleen and blood. Collectively, EDB protects against ischemic stroke injury by inhibiting the proinflammatory activation of microglia/macrophages and astrocytes and through reduction by invasion of circulating immune cells, which reduces central and peripheral inflammation following stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Chonnam National University, Gwangju 61186, Republic…
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Chonnam National University, Gwangju 61186, Republic of Korea.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: 2992294650@qq.com.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Chonnam National University, Gwangju 61186, Republic of Korea. Electronic address: kwanglee@chonnam.ac.kr.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: linliwz@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, D., Wang, Y., Shi, J., Jiang, W., Huang, W., Chen, K., Wang, X., Zhang, G., Li, Y., Cao, C., Lee, K. Y., & Lin, L. (2024). Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration. International Immunopharmacology, 130, 111700. https://doi.org/10.1016/j.intimp.2024.111700
Vancouver
Wang D, Wang Y, Shi J, Jiang W, Huang W, Chen K, et al. Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration. International Immunopharmacology. 2024;130:111700. doi:10.1016/j.intimp.2024.111700
BibTeX
@article{Wang2024,
author = {Wang, Dongxue and Wang, Yutao and Shi, Junfeng and Jiang, Wenyi and Huang, Wenting and Chen, Keyang and Wang, Xue and Zhang, Gongchun and Li, Yuankuan and Cao, Chengkun and Lee, Kwang-Youl and Lin, Li},
title = {Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration},
journal = {International Immunopharmacology},
year = {2024},
volume = {130},
pages = {111700},
doi = {10.1016/j.intimp.2024.111700}
}
EUVIMED